Diaceutics Plc Stock Net Income
| DIUXF Stock | USD 1.67 0.00 0.00% |
As of the 8th of February, Diaceutics PLC shows the Mean Deviation of 0.6535, coefficient of variation of 812.4, and Standard Deviation of 2.7. Diaceutics PLC technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm Diaceutics PLC risk adjusted performance, variance, as well as the relationship between the Variance and kurtosis to decide if Diaceutics PLC is priced favorably, providing market reflects its regular price of 1.67 per share. Please also check Diaceutics PLC information ratio, which is currently at 0.0898 to verify the company can sustain itself at a future point.
Diaceutics PLC's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Diaceutics PLC's valuation are provided below:Diaceutics PLC does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Diaceutics |
Diaceutics PLC 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Diaceutics PLC's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Diaceutics PLC.
| 11/10/2025 |
| 02/08/2026 |
If you would invest 0.00 in Diaceutics PLC on November 10, 2025 and sell it all today you would earn a total of 0.00 from holding Diaceutics PLC or generate 0.0% return on investment in Diaceutics PLC over 90 days. Diaceutics PLC is related to or competes with Japan Medical. Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for p... More
Diaceutics PLC Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Diaceutics PLC's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Diaceutics PLC upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.0898 | |||
| Maximum Drawdown | 21.9 |
Diaceutics PLC Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Diaceutics PLC's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Diaceutics PLC's standard deviation. In reality, there are many statistical measures that can use Diaceutics PLC historical prices to predict the future Diaceutics PLC's volatility.| Risk Adjusted Performance | 0.1062 | |||
| Jensen Alpha | 0.3009 | |||
| Total Risk Alpha | 0.0553 | |||
| Treynor Ratio | 1.23 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Diaceutics PLC's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Diaceutics PLC February 8, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1062 | |||
| Market Risk Adjusted Performance | 1.24 | |||
| Mean Deviation | 0.6535 | |||
| Coefficient Of Variation | 812.4 | |||
| Standard Deviation | 2.7 | |||
| Variance | 7.27 | |||
| Information Ratio | 0.0898 | |||
| Jensen Alpha | 0.3009 | |||
| Total Risk Alpha | 0.0553 | |||
| Treynor Ratio | 1.23 | |||
| Maximum Drawdown | 21.9 | |||
| Skewness | 8.12 | |||
| Kurtosis | 66.0 |
Diaceutics PLC Backtested Returns
Diaceutics PLC appears to be risky, given 3 months investment horizon. Diaceutics PLC secures Sharpe Ratio (or Efficiency) of 0.13, which denotes the company had a 0.13 % return per unit of standard deviation over the last 3 months. We have found sixteen technical indicators for Diaceutics PLC, which you can use to evaluate the volatility of the firm. Please utilize Diaceutics PLC's Standard Deviation of 2.7, coefficient of variation of 812.4, and Mean Deviation of 0.6535 to check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Diaceutics PLC holds a performance score of 10. The firm shows a Beta (market volatility) of 0.26, which means not very significant fluctuations relative to the market. As returns on the market increase, Diaceutics PLC's returns are expected to increase less than the market. However, during the bear market, the loss of holding Diaceutics PLC is expected to be smaller as well. Please check Diaceutics PLC's risk adjusted performance, variance, as well as the relationship between the Variance and kurtosis , to make a quick decision on whether Diaceutics PLC's price patterns will revert.
Auto-correlation | 0.00 |
No correlation between past and present
Diaceutics PLC has no correlation between past and present. Overlapping area represents the amount of predictability between Diaceutics PLC time series from 10th of November 2025 to 25th of December 2025 and 25th of December 2025 to 8th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Diaceutics PLC price movement. The serial correlation of 0.0 indicates that just 0.0% of current Diaceutics PLC price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Diaceutics PLC reported net income of 561 K. This is 99.84% lower than that of the Healthcare sector and 99.68% lower than that of the Diagnostics & Research industry. The net income for all United States stocks is 99.9% higher than that of the company.
Diaceutics Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Diaceutics PLC's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Diaceutics PLC could also be used in its relative valuation, which is a method of valuing Diaceutics PLC by comparing valuation metrics of similar companies.Diaceutics PLC is currently under evaluation in net income category among its peers.
Diaceutics Fundamentals
| Return On Equity | 0.0032 | |||
| Return On Asset | 3.0E-4 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0 % | |||
| Current Valuation | 54.7 M | |||
| Shares Outstanding | 84.47 M | |||
| Shares Owned By Insiders | 46.89 % | |||
| Shares Owned By Institutions | 47.72 % | |||
| Price To Earning | 112.00 X | |||
| Price To Book | 2.07 X | |||
| Price To Sales | 6.10 X | |||
| Revenue | 13.94 M | |||
| Gross Profit | 10.73 M | |||
| EBITDA | 2.35 M | |||
| Net Income | 561 K | |||
| Cash And Equivalents | 19.68 M | |||
| Cash Per Share | 0.23 X | |||
| Total Debt | 1.56 M | |||
| Debt To Equity | 0.04 % | |||
| Current Ratio | 11.41 X | |||
| Book Value Per Share | 0.49 X | |||
| Cash Flow From Operations | 570 K | |||
| Earnings Per Share | 0.01 X | |||
| Number Of Employees | 133 | |||
| Beta | 0.29 | |||
| Market Capitalization | 94.61 M | |||
| Total Asset | 45.01 M | |||
| Z Score | 36.0 | |||
| Net Asset | 45.01 M |
About Diaceutics PLC Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Diaceutics PLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Diaceutics PLC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Diaceutics PLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Diaceutics Pink Sheet
Diaceutics PLC financial ratios help investors to determine whether Diaceutics Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Diaceutics with respect to the benefits of owning Diaceutics PLC security.